Because Ranbaxy holds the firstfiler 180-day generic marketing exclusivity for atorvastatin, this prevents other generics from launching a generic Lipitor in the US before May 30, 2012. (Pfizer holds the right to launch an authorized generic.)
Market Data 
Markets 
AI
